Quantitative analysis of neurofibromatosis type 2 gene transcripts in meningiomas supports the concept of distinct molecular variants

Laboratory Investigation

Volumn 77, Issue 6, 1997, Pages 601-606

  Wellenreuther, Ruth ^a   Waha, Andreas ^a   Vogel, Ylin ^a   Lenartz, Doris ^b   Schramm, Johannes ^a   Wiestler, Otmar Dieter ^a   Von Deimling, Andreas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b KRANKENHAUS MERHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER CLASSIFICATION; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENINGIOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

GENES, NEUROFIBROMATOSIS 2; HUMANS; MEMBRANE PROTEINS; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM PROTEINS; NEUROFIBROMIN 2; TRANSCRIPTION, GENETIC; VARIATION (GENETICS);

EID: 0031445984     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Baserga SJ and Benz EJJ (1992). NF2 gene analysis distinguishes hemangiopericytoma from meningioma. Am J Pathol 147:1450-1455.
2. Daar IO and Maquat LE (1988). Premature translation termination mediates triosephosphate isomerase mRNA degradation. Mol Cell Biol 8:802-813.
3. De Vitis LR, Tedde A, Vitelle F, Ammannati F, Mennonna P, Bigozzi U, Montali E, and Papi L (1996). Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas. Hum Genet 97:632-637.
4. Harada T, Irving RM, Xuereb JH, Barton DE, Hardy DG, Moffat DA, and Maher ER (1996). Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma. J Neurosurg 84:847-851.
5. Hitotsumatsu T, Iwaki T, Kitamoto T, Mizoguchi M, Suzuki SO, Hamada Y, Fukui M, and Tateishi J (1997). Expression of neurofibromatosis 2 protein in human brain tumors: An immunohistochemical study. Acta Neuropathol (Berl) 93: 225-232.
6. Huynh DP, Mautner V, Baser ME, Stavrou D, and Pulst S-M (1997). Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas. J Neuropath Exp Neurol 56:382-390.
7. Jacoby LB, MacCollin M, Louis DN, Mohney T, Rubio MP, Pulaski K, Trofatter JA, Kley N, Seizinger B, Ramesh V, and Gusella JF (1994). Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3:413-419.
8. Joseph JT, Lisle DK, Jacoby LB, Paulus W, Barone R, Cohen ML, Roggendorf WH, Bruner JM, Gusella JF, and Louis DN (1995). NF2 gene analysis distinguishes hemangiopericytoma from meningioma. Am J Pathol 147:1450-1455.
9. Lee JH, Sundaram V, Stein DJ, Kinney SE, Stacey DW, and Golubic M (1997). Reduced expression of schwannomin/ merlin in human sporadic meningiomas. Neurosurgery 40: 578-587.
10. Lekanne Deprez RH, Bianchi A, Groen NA, Seizinger BR, Hagemeijer A, van Drunen E, Bootsma D, Koper JW, Avezaat CJJ, Kley N, and Zwarthoff EC (1994). Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54:1022-1029.
11. Mérel P, Hoang-Xuan K, Sanson M, Moreau-Aubry A, Bijlsma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X, Delattre JY, Poisson M, Theillet C, Hulsebos T, Delattre O, and Thomas G (1995). Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosom Cancer 13:211-216.
12. Ogasawara M, Matsubara Y, Mikami H, and Narisawa K (1994). Identification of two novel mutations in the methylmalonyl-CoA mutase gene with decreased levels of mutant mRNA in methylmalonic acidemia. Hum Mol Genet 3:867-872.
13. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Zuang K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldridge R, Aurias A, Delattre O, and Thomas G (1993). Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363:515-521.
14. Rouleau GA, Wertelecki W, Haines JL, Hobbs WJ, Trofatter JA, Seizinger BR, Martuza RL, Superneau DW, Conneally PM, and Gusella JF (1987). Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 329:246-248.
15. Ruiz-Echevarria M, Czaplinski K, and Peltz SW (1996). Making sense of nonsense in yeast. Trends Biochem Sci 21:433-438.
16. Ruttledge MH, Xie Y-G, Han F-Y, Giovanni M, Janson M, Fransson I, Werelius B, Delattre O, Thomas G, Evans G, and Dumanski JP (1994). Physical mapping of the NF2/ meningioma region on the human chromosome 22q12. Genomics 19:52-59.
17. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, and Pulst S-M (1994). Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 3:885-891.
18. Trofatter JA, MacCollin MM, Ruttner JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, and Gusella JF (1993). A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800.
19. Waha A, Watzka M, Koch A, Pietsch T, Przkora R, Peters N, Wiestler OD, and von Deimling A (in press, 1998). A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes. Brain Pathol.
20. Wellenreuther R, Kraus J, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, and von Deimling A (1995). Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 146:827-832.